Susquehanna International Group’s Gossamer Bio GOSS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.76K Sell
450
-2,514
-85% -$56.1K ﹤0.01% 13183
2026
Q1
$78.2K Sell
2,964
-504
-15% -$63.4K ﹤0.01% 12468
2025
Q4
$860K Buy
3,468
+3,115
+882% +$711K ﹤0.01% 7528
2025
Q3
$74.2K Buy
+353
New +$62.2K ﹤0.01% 11717
2025
Q1
– Sell
-5,808
Closed -$418K – 12845
2024
Q4
$418K Sell
5,808
-28
-0.5% -$1.92K ﹤0.01% 9115
2024
Q3
$462K Sell
5,836
-225
-4% -$17.3K ﹤0.01% 8646
2024
Q2
$436K Buy
6,061
+32
+0.5% +$1.92K ﹤0.01% 8599
2024
Q1
$569K Sell
6,029
-2,002
-25% -$176K ﹤0.01% 8209
2023
Q4
$585K Buy
8,031
+3,626
+82% +$214K ﹤0.01% 8279
2023
Q3
$292K Buy
4,405
+3,159
+254% +$291K ﹤0.01% 9400
2023
Q2
$120K Buy
1,246
+785
+170% +$78.2K ﹤0.01% 10800
2023
Q1
$46.5K Sell
461
-747
-62% -$114K ﹤0.01% 11722
2022
Q4
$210K Sell
1,208
-597
-33% -$393K ﹤0.01% 10017
2022
Q3
$1.73M Buy
1,805
+1,587
+728% +$1.58M ﹤0.01% 5237
2022
Q2
$146K Sell
218
-1,000
-82% -$620K ﹤0.01% 11055
2022
Q1
$845K Buy
+1,218
New +$940K ﹤0.01% 7574
2021
Q3
– Sell
-1,399
Closed -$909K – 13025
2021
Q2
$909K Sell
1,399
-362
-21% -$251K ﹤0.01% 8028
2021
Q1
$1.3M Buy
1,761
+441
+33% +$356K ﹤0.01% 7024
2020
Q4
$1.02M Sell
1,320
-529
-29% -$417K ﹤0.01% 6682
2020
Q3
$1.83M Buy
1,849
+1,644
+802% +$1.74M ﹤0.01% 4781
2020
Q2
$213K Sell
205
-624
-75% -$628K ﹤0.01% 8927
2020
Q1
$673K Buy
829
+585
+240% +$611K ﹤0.01% 6287
2019
Q4
$305K Sell
244
-1,232
-83% -$1.99M ﹤0.01% 7977
2019
Q3
$1.98M Buy
+1,476
New +$2.35M ﹤0.01% 4214

Other funds holding GOSS

Susquehanna International Group's GOSS Position: Q2 2026 in Review

Susquehanna International Group increased its Gossamer Bio (GOSS) stake by 182% in Q2 2026, buying an estimated $69K and bringing the position to 4,788 shares worth $63K. The position accounts for ﹤0.01% of the portfolio, ranked #12748.

Susquehanna International Group first reported a position in GOSS in Q3 2019 and has held it in 24 quarters since. The position peaked at $3.21M in Q1 2025. 166 funds tracked by Wall St. Rank hold GOSS as of Q2 2026.

  • Susquehanna International Group held 4,788 shares of Gossamer Bio worth $63K as of Q2 2026.
  • Susquehanna International Group bought 3,091 Gossamer Bio shares in Q2 2026, an estimated $69K.
  • Gossamer Bio made up ﹤0.01% of Susquehanna International Group's portfolio in Q2 2026, its #12748 holding.
  • Susquehanna International Group first reported a position in Gossamer Bio in Q3 2019 and has held it in 24 quarters since.
  • Susquehanna International Group's Gossamer Bio position peaked at $3.21M in Q1 2025.
  • 166 funds tracked by Wall St. Rank held Gossamer Bio as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.